THC and CBD are the two most abundant active compounds in cannabis, and they affect your body in fundamentally different ways. THC is the compound that gets you high. CBD does not. Despite sharing an identical chemical formula, a single structural difference between the two molecules creates vastly different experiences, legal statuses, and medical applications.
Same Formula, Different Shape
THC and CBD both have the molecular formula C₂₁H₃₀O₂, with twenty-one carbon atoms, thirty hydrogen atoms, and two oxygen atoms arranged in nearly the same layout. The critical difference: where THC has a closed ring in its structure, CBD has an open hydroxyl group in that same position. That one variation changes how each molecule fits into receptors in your brain and body, which is why one compound produces euphoria and the other doesn’t.
Why THC Gets You High and CBD Doesn’t
Your body has its own system of cannabinoid receptors, called the endocannabinoid system, that helps regulate mood, appetite, pain, and memory. Two key receptors in this system are CB1 (concentrated in the brain) and CB2 (found mostly in the immune system and peripheral tissues).
THC binds directly to CB1 receptors in the brain as a partial agonist, meaning it activates those receptors enough to alter neurotransmitter release and produce the characteristic high: euphoria, altered time perception, increased appetite, and heightened sensory experiences. It also partially activates CB2 receptors, contributing to effects on inflammation and immune function.
CBD takes a completely different approach. It has very low affinity for both CB1 and CB2 receptors and doesn’t activate them the way THC does. Instead, CBD acts as a negative allosteric modulator of CB1 receptors. In practical terms, this means CBD changes the shape of the receptor so that other compounds (including THC) bind to it less effectively. This is one reason CBD can actually blunt some of THC’s effects, like anxiety and sedation, when the two are taken together.
Medical Uses With FDA Approval
Both compounds have FDA-approved medications, though for very different conditions. Epidiolex, a purified CBD drug, is approved for treating seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex in patients one year of age and older. It remains the only FDA-approved drug containing CBD.
On the THC side, synthetic versions have been approved for different purposes. Marinol and Syndros contain dronabinol (synthetic THC) and are used to treat anorexia and weight loss in AIDS patients. Cesamet contains nabilone, a compound with a structure similar to THC, and is also approved for therapeutic use. These medications deliver controlled doses of THC without requiring patients to smoke or vape cannabis.
Pain Relief: What the Research Shows
A review of 25 randomized controlled trials covering over 2,300 participants compared different cannabinoid products for chronic pain lasting one to six months. Products with high THC-to-CBD ratios and those with roughly equal THC-to-CBD ratios both showed modest reductions in pain severity. However, those reductions came with moderate-to-large increases in dizziness, sedation, and nausea.
Products with low THC-to-CBD ratios (meaning mostly CBD with little THC) did not appear to improve pain outcomes. CBD alone didn’t increase harmful side effects, but it also didn’t move the needle much on pain. This suggests THC is the more active pain-relieving component, while CBD’s role in pain management may depend on having meaningful amounts of THC alongside it.
Side Effects Compared
THC’s side effects are largely tied to its psychoactive nature: impaired memory and attention, slowed reaction time, increased heart rate, dry or red eyes, anxiety, and difficulty performing routine tasks. At higher doses, some people experience paranoia or panic.
CBD is generally considered well tolerated, with side effects that tend to be mild: fatigue, changes in appetite, and digestive discomfort. But the interaction between the two compounds is more complicated than most people assume.
A study from Johns Hopkins found that when the same dose of THC was delivered in a high-CBD cannabis extract (as an edible), participants experienced stronger drug effects across the board compared to THC alone. Heart rate increased by 25 beats per minute above baseline with the THC-plus-CBD combination, versus only 10 beats per minute with THC alone. Participants also reported more unpleasant drug effects, greater difficulty with routine tasks, and more impairment on memory and attention tests. This challenges the popular idea that adding CBD to THC always makes the experience smoother or safer, at least in edible form.
Legal Status
Under the 2018 Farm Bill, hemp is defined as any part of the cannabis plant containing no more than 0.3% delta-9 THC on a dry-weight basis. CBD products derived from hemp that fall below this threshold are federally legal, though state laws vary. Cannabis products above the 0.3% THC limit remain classified as marijuana under federal law and are controlled substances, even in states that have legalized recreational or medical use at the state level.
This distinction means most CBD oils, gummies, and topicals you see in stores are derived from hemp and marketed as containing less than 0.3% THC. THC products, by contrast, are only legally sold through licensed dispensaries in states with medical or recreational cannabis programs.
CBD Products and Drug Testing
CBD itself won’t trigger a positive result on a standard drug test, which screens for THC metabolites. But that doesn’t mean you’re in the clear if you use CBD products regularly. Hemp-derived CBD products can legally contain up to 0.3% THC, and with regular use, those trace amounts can accumulate in your body to levels that show up on a drug screen.
The problem is often worse than labels suggest. Reports from the FDA and independent labs have found CBD products containing significantly more THC than would be expected from legal hemp sources. People across the country have reported failing workplace drug tests after using only CBD products. If you’re subject to drug testing, this is a real and documented risk, not a theoretical one.
How Cannabis Varieties Differ
Different cannabis plant types naturally produce different ratios of THC and CBD. Sativa strains typically have higher THC and lower CBD levels. Indica strains tend to have higher CBD content, though their THC levels aren’t necessarily lower. Most hybrid strains on the market today have been bred to maximize THC, but each cultivar has its own unique ratio. Ruderalis, a less common variety, typically has little THC and higher amounts of CBD, making it a common starting point for hemp cultivation.
For consumers, these natural variations matter because the ratio of THC to CBD in a product shapes the overall experience. A product with equal parts THC and CBD will feel different from one that’s almost entirely THC or entirely CBD, even if the total milligrams of cannabinoids are the same.